Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2003JAIDS Journal of Acquired Immune Deficiency Syndromes

A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJerry O. SternBoehringer Ingelheim (United States)PRPatrick RobinsonUniversity of North Carolina at CharlotteJLJames E. LoveZOLL Medical Corporation (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stern et al. (2003) studied this question.

synapsesocial.com/papers/6a8ddae8a658c8b40988e241https://doi.org/10.1097/00126334-200309011-00005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine2003 · 123 citations
  2. 2Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study2000 · 219 citations
  3. 3Lack of Hepatotoxicity Associated With Nonnucleoside Reverse Transcriptase Inhibitors2002 · 72 citations
  4. 4Hepatotoxicity Associated With Isoniazid Preventive Therapy1999 · 469 citations
  5. 5Antiretroviral Treatment Simplification With Nevirapine in Protease Inhibitor–Experienced Patients With HIV-Associated Lipodystrophy2001 · 167 citations